Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

BEVA launches antimicrobial monitoring campaign
"It is important that we demonstrate, as a sector, that our usage of antimicrobials is responsible and proportionate, to ensure continued access." - Bruce Bladon
MonitorME will collect data from equine practices across the UK.

The British Equine Veterinary Association (BEVA) has launched a new campaign, as it aims to better understand how antibiotics are used in the equine sector.

The MonitorME project was launched this month to gather antimicrobial usage data from equine practices across the UK.

BEVA is urging practices to share usage data from their practice management systems to the BEVA office. This will be collated to create a nationwide data set of antimicrobial usage in the equine sector.

The information will ideally include the total mg of each antimicrobial used. It should also include the total number of horses treated by the practice in the past year, regardless of whether they were treated with antibiotics, and their average weight.

The data will be analysed and collated into an annual report, which will then be published on the BEVA MonitorME webpage.

The organisation’s 2023 report on antimicrobial usage is already available, but will be continually updated as practices submit their 2023 data. BEVA has already started collating data from 2024.

The new campaign will feature as a key theme at this year’s BEVA Congress, as the organisation aims to demonstrate the sector’s responsible approach to antimicrobial usage.

BEVA president Bruce Bladon said: “Growing resistance to antibiotics is a very serious public health crisis, which is why I have chosen it as the overriding theme for my presidential year and for the forthcoming BEVA Congress,

“The World Health Organisation has the usage of veterinary antimicrobials firmly in their sights and the possibility of legislation being implemented to limit our access to these vital drugs is becoming ever more likely.
 
“It is important that we demonstrate, as a sector, that our usage of antimicrobials is responsible and proportionate, to ensure continued access. Taking part in a project like this is, without a doubt, the right thing to do.”

There is more information on the BEVA MonitorME webpage, or practices can submit their data to antibiotics@beva.org.uk for collation into the 2024 data set.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
Wales licenses Bluetongue vaccines for voluntary use

The Welsh government has approved three Bluetongue vaccines for emergency use in Wales.

From 1 March an online general licence will become available for the vaccines' use. They will then be obtainable on prescription and can be sold by veterinary practices.

After appropriate guidance, livestock keepers will be permitted to administer the vaccines themselves. The vaccines must be prescribed by a veterinary surgeon and detailed vaccination records must be kept for five years.

The decision comes as Bluetongue virus (BTV-3) continues to spread across England. The three vaccines are already licensed for use in England.

Richard Irvine, CVO for Wales, said: "This decision to licence these vaccines was informed by our recent risk assessment indicating that Wales is now at high risk of experiencing an incursion of Bluetongue this year.

"Our primary aim is to keep Bluetongue out of Wales through biosecurity, vigilance and safe sourcing of livestock."